Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Renzoni

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Current Opinion in Pulmonary Medicine|July 14, 2020
Oxygen for interstitial lung diseasesYet H Khor, David J F Smith, Kerri A Johannson, et al.
Annals of the American Thoracic Society|August 20, 2019
Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological CharacteristicsFelix Chua, Sujal R Desai, Andrew G Nicholson, et al.
Experimental Cell Research|February 21, 2006
Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: insight into the functional role of mutant fibrillin-1Rajesh P Menon, Malini R Menon, Xu Shi-Wen, et al.
Respiratory Medicine|May 5, 2018
Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitisJoseph Jacob, Arlette Odink, Anne Laure Brun, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 12, 2007
Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumoniasAlberto Ricci, Paolo Graziano, Elena Bronzetti, et al.
ERJ Open Research|March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosisWim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Respiration; International Review of Thoracic Diseases|April 12, 2017
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received PirfenidoneMichael Kreuter, Paolo Spagnolo, Wim Wuyts, et al.
The European Respiratory Journal|October 21, 2017
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosisMirjam J G van Manen, Surinder S Birring, Carlo Vancheri, et al.
The Lancet. Respiratory Medicine|April 7, 2016
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysisMichael Kreuter, Wim Wuyts, Elisabetta Renzoni, et al.
The Lancet. Respiratory Medicine|September 7, 2016
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' replyMichael Kreuter, Wim Wuyts, Elisabetta Renzoni, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Current Opinion in Pulmonary Medicine|July 14, 2020
Oxygen for interstitial lung diseasesYet H Khor, David J F Smith, Kerri A Johannson, et al.
Annals of the American Thoracic Society|August 20, 2019
Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological CharacteristicsFelix Chua, Sujal R Desai, Andrew G Nicholson, et al.
Experimental Cell Research|February 21, 2006
Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: insight into the functional role of mutant fibrillin-1Rajesh P Menon, Malini R Menon, Xu Shi-Wen, et al.
Respiratory Medicine|May 5, 2018
Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitisJoseph Jacob, Arlette Odink, Anne Laure Brun, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 12, 2007
Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumoniasAlberto Ricci, Paolo Graziano, Elena Bronzetti, et al.
ERJ Open Research|March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosisWim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Respiration; International Review of Thoracic Diseases|April 12, 2017
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received PirfenidoneMichael Kreuter, Paolo Spagnolo, Wim Wuyts, et al.
The European Respiratory Journal|October 21, 2017
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosisMirjam J G van Manen, Surinder S Birring, Carlo Vancheri, et al.
The Lancet. Respiratory Medicine|April 7, 2016
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysisMichael Kreuter, Wim Wuyts, Elisabetta Renzoni, et al.
The Lancet. Respiratory Medicine|September 7, 2016
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' replyMichael Kreuter, Wim Wuyts, Elisabetta Renzoni, et al.
Pageof 5